A  drug discovery and development company with “first-in-class” drugs for respiratory diseases


Investors

Verona Pharma is listed on the London Stock Exchange under the VRP.L ticker and on the Frankfurt Xetra platform under the I9S ticker. Read more here about investing in Verona Pharma

Verona Pharma shares

Powered by Ekonomys Quotes 6

Pipeline

Verona Pharma is focused on developing new drugs for a range of respiratory diseases. See our Pipeline

New pipeline - smaller2

Partners

A key component of Verona Pharma’s business strategy is out-licensing its “first-in-class” drug programmes to suitable development and commercialisation partners. To discuss partnering opportunities, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.

Verona Pharma plc, 3 More London Riverside. London SE1 2RE
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. | Tel: +44 (0)203 283 4200
To provide feedback or report problems with the website: This email address is being protected from spambots. You need JavaScript enabled to view it.